PharmaDispatch 2018 - video recap #3: The National Medicines Policy

This is a preview of subscriber content

Subscribe now to continue reading.

The first panel of the day featured a discussion on the future of the National Medicines Policy with PBAC chair Professor Andrew Wilson; Hepatitis Australia president and former senior Department of Health official, Felicity McNeill PSM; Michala Fischer-Hansen, managing director of Novo Nordisk and Medicines Australia board member; and, PBAC deputy chair and consumer representative, as well as deputy chair of the Consumers Health Forum, Jo Watson. …

Subscribe now to continue reading.

PharmaDispatch 2018 - video recap #3: The National Medicines Policy

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact

Sign In

PharmaDispatch 2018 - video recap #3: The National Medicines Policy

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

Follow Us

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact